We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
+6.47%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.15B
AUM Growth
-$105M
Cap. Flow
-$153M
Cap. Flow %
-13.33%
Top 10 Hldgs %
19.03%
Holding
431
New
73
Increased
184
Reduced
112
Closed
35

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$13.5M
2
EVH icon
Evolent Health
EVH
+$9.49M
3
RCL icon
Royal Caribbean
RCL
+$8.69M
4
VTR icon
Ventas
VTR
+$7.23M
5
ARGX icon
argenx
ARGX
+$7.04M

Top Sells

Rank Stock Value
1
CIXX
CI Financial Corp.
CIXX
+$27M
2
SCHW
Charles Schwab
SCHW
+$18.3M
3
ABT icon
Abbott
ABT
+$15.6M
4
BEKE icon
KE Holdings
BEKE
+$15.5M
5
HTHT icon
Huazhu Hotels Group
HTHT
+$15.2M

Sector Composition

Rank Sector Weight
1 Healthcare 44.36%
2 Consumer Discretionary 13.29%
3 Technology 13.16%
4 Financials 10.68%
5 Industrials 6.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THO icon
26
Thor Industries
THO
$4.11B
$13.9M 1.22%
175,000
-25,000
-13% -$2.21M
INCY icon
27
Incyte
INCY
$24.5B
$13.9M 1.21%
192,505
-54,679
-22% -$4.28M
NBIX icon
28
Neurocrine Biosciences
NBIX
$15.9B
$13.5M 1.18%
133,656
-3,794
-3% -$395K
CHE icon
29
Chemed
CHE
$7.07B
$13.4M 1.17%
25,000
– –
GL icon
30
Globe Life
GL
$13.8B
$13.3M 1.16%
120,579
-14,695
-11% -$1.72M
RCM
31
DELISTED
R1 RCM Inc. Common Stock
RCM
$12M 1.04%
797,006
-422,139
-35% -$5.78M
GKOS icon
32
Glaukos
GKOS
$11B
$10.5M 0.92%
209,938
+7,025
+3% +$341K
ISEE
33
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$10.1M 0.88%
413,115
+177,556
+75% +$3.89M
EVH icon
34
Evolent Health
EVH
$471M
$9.73M 0.85%
+300,000
New +$9.49M
NTRA icon
35
Natera
NTRA
$45.5B
$9.27M 0.81%
166,879
+85,710
+106% +$4.11M
OPCH icon
36
Option Care Health
OPCH
$3.57B
$9.05M 0.79%
285,000
-15,000
-5% -$449K
RCL icon
37
Royal Caribbean
RCL
$82.4B
$8.6M 0.75%
+131,706
New +$8.69M
VRTS icon
38
Virtus Investment Partners
VRTS
$1.12B
$8.57M 0.75%
45,000
-5,000
-10% -$1.01M
CVS icon
39
CVS Health
CVS
$121B
$8.33M 0.73%
112,134
-98,354
-47% -$8.25M
ANSS
40
DELISTED
Ansys
ANSS
$8.28M 0.72%
24,880
-1,060
-4% -$299K
MED icon
41
Medifast
MED
$130M
$7.78M 0.68%
75,000
-75,400
-50% -$8.36M
NVDA icon
42
NVIDIA
NVDA
$5.43T
$7.7M 0.67%
277,230
-21,800
-7% -$472K
PRVB
43
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$7.59M 0.66%
314,862
-8,033
-2% -$101K
AWK icon
44
American Water Works
AWK
$26.8B
$7.56M 0.66%
51,615
+9,883
+24% +$1.46M
EXAS
45
DELISTED
Exact Sciences
EXAS
$7.33M 0.64%
108,057
+21,243
+24% +$1.37M
AMZN icon
46
Amazon
AMZN
$2.88T
$7.22M 0.63%
69,938
+13,676
+24% +$1.32M
ARGX icon
47
argenx
ARGX
$54.8B
$7.09M 0.62%
+19,026
New +$7.04M
RSG icon
48
Republic Services
RSG
$65.6B
$6.94M 0.61%
51,298
+26,299
+105% +$3.36M
VTR icon
49
Ventas
VTR
$45.7B
$6.72M 0.59%
154,932
+150,000
+3,041% +$7.23M
URI icon
50
United Rentals
URI
$70.3B
$6.67M 0.58%
16,845
-855
-5% -$359K
1
2
3 4 5

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
MAMU
Marathon Asset Management (UK) London, United Kingdom $2.61B AUM 27.14% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q1 2023 Portfolio in Review

As of Q1 2023, Lombard Odier Asset Management (Switzerland) held 431 positions worth $1.15B, down 8.4% from $1.25B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lombard Odier Asset Management (Switzerland) withdrew a net $153M in Q1 2023, closing 35 positions and reducing 112 holdings. Its most notable exit was CI Financial Corp., an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Lombard Odier Asset Management (Switzerland) opened a new position in Evolent Health worth $9.73M.

  • Lombard Odier Asset Management (Switzerland)'s largest Q1 2023 buy was Evolent Health: 300,000 shares worth $9.73M.
  • Lombard Odier Asset Management (Switzerland) added most to Vertex Pharmaceuticals in Q1 2023, an estimated $13.5M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q1 2023 reduction was Charles Schwab, cutting an estimated $18.3M.
  • Lombard Odier Asset Management (Switzerland) fully exited CI Financial Corp. in Q1 2023, selling an estimated $27M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 19% of its $1.15B portfolio in Q1 2023.
  • Lombard Odier Asset Management (Switzerland) opened 73 new positions and closed 35 in Q1 2023.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 8.4% quarter-over-quarter to $1.15B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2023, filed 15 May 2023.